High-risk patients that are both hormone receptor-positive (HR) and HR-negative were selected for this trial. Investigators reported that the Enhertu-THP arm of the trial reached a pCR rate of ...
Until all indicators align positively, the consolidation phase may continue, with the 25,700–25,600 zone acting as key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback